FDG-PET-Stratified R-DICEP and R-Beam/ASCT For Diffuse Large B-Cell Lymphoma
Status:
Completed
Trial end date:
2015-05-19
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate:
1. whether an imaging test called a PET (Positron emission tomography) scan performed after
two cycles of standard chemotherapy is able to identify patients who have a high cure
rate after completing standard chemotherapy alone; and
2. whether high dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT)
when used in combination with an antibody called Rituximab results in high cure rates
for those patients predicted to do poorly with standard chemotherapy by the PET scan.
Phase:
N/A
Details
Lead Sponsor:
AHS Cancer Control Alberta Alberta Health Services